Meeting
2017 ASCO Annual Meeting
The impact of quality and quantity of visceral fat on survival outcome of early-stage breast cancer patients with prior chemotherapy.
Authors
Toshiaki Iwase
Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX
Toshiaki Iwase , Takafumi Sangai , Masahiro Sakakibara , Takeshi Nagashima , Masayuki Ohtsuka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Citation
J Clin Oncol 35, 2017 (suppl; abstr 584)
DOI
10.1200/JCO.2017.35.15_suppl.584
Abstract #
584
Poster Bd #
184
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2017 Cancer Survivorship Symposium
Prevalence of sarcopenia and predictors of body composition among women with early-stage breast cancer.
First Author: Elizabeth (Cespedes) Feliciano
Poster
2015 Breast Cancer Symposium
Impact of breast cancer treatment on body mass index (BMI) over time.
First Author: Raquel E. Reinbolt
Poster
2013 ASCO Quality Care Symposium
Bridging to survivorship in breast cancer: Learning how treatment impacts mental health among early-stage breast cancer survivors.
First Author: Debra A. Patt